Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Bingbing Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of external-use medicines and transdermal drug delivery systems. The company is most recognized for its flagship "Bingbing" brand of fever-cooling patches, which holds a significant market share in the Chinese pediatric OTC segment. Beyond fever care, the firm produces a variety of medicated patches, ointments, and gels designed for pain management, respiratory relief, and skin conditions. Operating from its GMP-certified facilities in Wuhan, the company integrates traditional topical therapy with modern hydrogel technology to serve both domestic and international healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Bingbing Pharmaceutical.